IPF Respiratory Symptoms Management - Current Evidence
- PMID: 35966835
- PMCID: PMC9368785
- DOI: 10.3389/fmed.2022.917973
IPF Respiratory Symptoms Management - Current Evidence
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic disease of the lungs which is characterized by heavy symptom burden, especially in the last year of life. Despite recently established anti-fibrotic treatment IPF prognosis is one of the worst among interstitial lung diseases. In this review available evidence regarding pharmacological and non-pharmacological management of the main IPF symptoms, dyspnea and cough, is presented.
Keywords: ambulatory oxygen therapy (AOT); breathlessness; cough; dyspnea; high flow nasal cannula (HFNC); idiopathic pulmonary fibrosis (IPF); non-invasive positive pressure ventilation (NIPPV); non-invasive ventilation (NIV).
Copyright © 2022 Janowiak, Szymanowska-Narloch and Siemińska.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. . An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. (2013) 188:733–48. 10.1164/rccm.201308-1483ST - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
